US Savings Top $338bn In 2020
As Savings Figure Linked To Biosimilars More Than Trebles To $7.9bn
Savings achieved in the US through the use of generics and biosimilars hit a new high in 2020, reaching $338bn, according to new figures released by the AAM.
